Open tender · Germany · Contract notice
Open house Arzneimittelrabattverträge Emtricitabin, Tenofovirdisoproxil und Rilpivirin, ATC J05AR08
AOK Bayern - Die Gesundheitskasse
AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open house Arzneimittelrabattverträge Emtricitabin, Tenofovirdisoproxil und Rilpivirin, ATC J05AR08”. Bids close on 3 July 2028.
The work
Non-exclusive discount agreements for the drug combination Emtricitabin, Tenofovirdisoproxil and Rilpivirin, ATC J05AR08.
- Identical and non-negotiable discount agreements
- Proof of reliability via a signed declaration
- Submission of contract and drug list
Key facts
- Contract period
- From 01.09.2026 to 31.08.2028
- Evaluation
- Not a competitive tender, but an open-house model for non-exclusive agreements.
What it takes to qualify
Worth a closer look
- The document is in German and appears to be a public procurement notice for a non-exclusive discount agreement model (open-house). The term 'Arzneimittelrabattverträge' translates to 'drug discount agreements'. The tender is for a specific drug combination (Emtricitabin, Tenofovirdisoproxil and Rilpivirin). The AOK Bayern is the contracting authority.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- ausgefüllte und unterzeichnete Eigenerklärung zur Zuverlässigkeitmust be signed and include proof of authority or power of attorney
- ausgefüllter und unterzeichneter Vertragincludes power of attorney or trade register extract
- ausgefüllte und unterzeichnete Anlage "Festlegung der vertragsgegenständlichen Arzneimittel"part of the contract submission package
- Handunterschriebene Unterlagen in 2-facher Fassung im Originalsent to AOK Bayern address
- Elektronische Unterlagen mit qualifizierter elektronischer Signatursubmitted via dtvp.de communication area